Filing Details
- Accession Number:
- 0001179022-17-000071
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-12-08 16:36:35
- Reporting Period:
- 2017-12-08
- Accepted Time:
- 2017-12-08 16:36:35
- Original Submission Date:
- 2017-12-08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1412377 | Marc Rubin | C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-08 | 7,000 | $1.85 | 55,581 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The footnote on the original Form 4, filed on December 8, 2017, incorrectly indicated that the shares were sold, instead of purchased, in multiple transactions. The shares were purchased in multiple transactions at prices ranging from $1.819 to $1.92. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.